Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) affect 17–46% of Western countries, making coexistence with other liver diseases inevitable. We investigated the prevalence and clinical significance of NAFLD/NASH or the components of metabolic syndrome...

全面介紹

書目詳細資料

發表在:	JHEP Reports
Main Authors:	Kalliopi Zachou, Kalliopi Azariadis, Ellina Lytvyak, Romée J.A.L.M. Snijders, Atsushi Takahashi, Nikolaos K. Gatselis, Mercedes Robles, Raul J. Andrade, Christoph Schramm, Ansgar W. Lohse, Atsushi Tanaka, Joost P.H. Drenth, Aldo J. Montano-Loza, George N. Dalekos
格式:	Article
語言:	英语
出版:	Elsevier 2023-08-01
主題:	Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Metabolic dysfunction-associated fatty liver disease Autoimmune hepatitis
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S258955592300109X